Avalyn Pharma Inc. (AVLN) vs Novavax, Inc. (NVAX)
- Avalyn Pharma Inc. AVLN 27.88 −6.32%
- Novavax, Inc. NVAX 7.95 −1.36%
Avalyn Pharma Inc. and Novavax, Inc. are both Biotechnology companies. Avalyn Pharma Inc. and Novavax, Inc. are of similar size ($1.3B and $1.2B). Avalyn Pharma Inc. has the higher net margin (0.00% vs −18.6%) and the lower return on invested capital (−127.6% vs 0.00%). Across the 10 metrics below, Avalyn Pharma Inc. leads on 6 and Novavax, Inc. on 4.
Valuation
Profitability
| Metric | AVLN | NVAX | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 78.01% | 70.18% |
| Operating margin | 0.00% | (21.23%) | 0.00% |
| Net margin | 0.00% | (18.64%) | 0.00% |
| Free cash flow margin | 0.00% | (59.25%) | 0.00% |
| Return on equity | 0.00% | 41.08% | (50.72%) |
| Return on assets | 0.00% | (7.42%) | (45.56%) |
| Return on invested capital | (127.60%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack